The Role of Muscarinic M2 and M3 Receptor Subtypes in Cardiopulmonary Responsiveness: Insights from In Vivo Murine Models

Loading...
Thumbnail Image

Authors

Vincent, Sandra

Date

Type

thesis

Language

eng

Keyword

Murine Models , Airway Hyperresponsiveness , M3Dq DREADD , M3 Muscarininc Antagonists , Muscarinic Receptors

Research Projects

Organizational Units

Journal Issue

Alternative Title

Abstract

Muscarinic receptors play an important role in cholinergic transmission and physiologic events. However, the study of the mechanisms by which muscarinic receptors mediate cardiopulmonary responses have been hampered by the homology of the five muscarinic receptor subtypes. We pursued three distinct methodologic approaches using murine models to dissect the fundamental roles and mechanisms of muscarinic receptor subtypes M2 (M2R) and M3 (M3R) within integrative physiology. Firstly, the role of M2R and M3R was evaluated in the development of airway hyperresponsiveness (AHR) in ovalbumin sensitized murine models lacking functional M2Rs and M3Rs. We provide novel evidence that the M3R, but not M2R, was critical for allergen-induced AHR, based on respiratory mechanics during airway challenge. The lack of the M3R also resulted in an unexpected bronchoconstrictor hyperresponsive phenotype independent of OVA sensitization and inflammation. Next, we examined the cardiopulmonary impact of skeletal M3R (activation of Gq G-protein pathway) on thermoregulation and cardiopulmonary function in a muscarinic (M3Dq) Designer Receptor Exclusively Activated by Designer Drug (DREADD) model. Based on telemetry from freely behaving mice, skeletal M3Dq expression had no impact on the daily cardiopulmonary phenotype, whereas, activation of skeletal M3Dq by Clozapine N-Oxide elicited a phenotype characterized by reduced ventilation, heart rate and body temperature, consistent with a presumptive reduction in metabolism. Lastly, we tested the ability of two novel structure-based designed muscarinic antagonists, ABH 423 and JHH 378, to inhibit differentially, the M3R over the M2R in a C57BL/6 murine model. Both compounds demonstrated a 4,000 x or greater -fold in vivo selectivity (p<0.001) of the M3R over the M2R, which was reflected in the inhibition of methacholine-induced bronchoconstriction and preservation of methacholine-induced bradycardia. Our findings revealed: 1. the key role of muscarinic M3 receptors in the development of airway responsiveness, 2. the integrated cardiopulmonary response due to skeletal muscle M3Dq pathway activation, possibly linked to torpor and, 3. the first pre-clinical data for structure-based highly selective M3R antagonists with therapeutic potential for obstructive lung disease.

Description

Citation

Publisher

License

Queen's University's Thesis/Dissertation Non-Exclusive License for Deposit to QSpace and Library and Archives Canada
ProQuest PhD and Master's Theses International Dissemination Agreement
Intellectual Property Guidelines at Queen's University
Copying and Preserving Your Thesis
This publication is made available by the authority of the copyright owner solely for the purpose of private study and research and may not be copied or reproduced except as permitted by the copyright laws without written authority from the copyright owner.

Journal

Volume

Issue

PubMed ID

External DOI

ISSN

EISSN